Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 2/20 | 0.50 |
| ▸ | FNTB | P49356 | 2/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 2/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.39 |
| ▸ | PPARG | P37231 | 6/20 | 0.39 |
| ▸ | PPARD | Q03181 | 6/20 | 0.39 |
| ▸ | PPARA | Q07869 | 6/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | TLR2 | O60603 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | FABP4 | P15090 | 2/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6672085 | 0.93 | FNTA (0.59) | FNTAFNTBTHRBPGGT1BCES1 | |
| SCHEMBL14324886 | 0.93 | FNTA (0.59) | FNTAFNTBTHRBPGGT1BCES1 | |
| SCHEMBL2965617 | 0.91 | FNTA (0.62) | FNTAFNTBTHRBPGGT1BCES1 | |
| SCHEMBL6667404 | 0.91 | FNTA (0.62) | FNTAFNTBTHRBPGGT1BCES1 | |
| SCHEMBL7856849 | 0.91 | FNTA (0.62) | FNTAFNTBTHRBPGGT1BCES1 | |
| SCHEMBL6665849 | 0.91 | FNTA (0.62) | FNTAFNTBTHRBPGGT1BCES1 | |
| SCHEMBL2965612 | 0.91 | FNTA (0.62) | FNTAFNTBTHRBPGGT1BCES1 | |
| SCHEMBL3596261 | 0.86 | HDAC3 (0.43) | FNTAFNTBTHRBPGGT1BCES1 | |
| SCHEMBL1276172 | 0.86 | HDAC3 (0.43) | FNTAFNTBTHRBPGGT1BCES1 | |
| Hydrochloric Acid SCHEMBL10322255 | 0.84 | FNTA (0.42) | FNTAFNTBTHRBPGGT1BCES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025018283-A1 | MEDICAL INSTRUMENT AND MANUFACTURING METHOD THEREFOR | テルモ株式会社 | 2025-01-23 | — | — | WO | claimed |
| EP-1201720-B1 | Printing fluid additives promoting overcoat adhesion | HEWLETT PACKARD CO (US) | 2004-09-15 | — | — | EP | claimed |
| WO-2003068898-A1 | WASHING AND CLEANING FORMULATIONS THAT CONTAIN ANTIMICROBIAL POLYMERS | CREAVIS GESELLSCHAFT FÜR TECHNOLOGIE UND INNOVATION MBH (DE) | 2003-08-21 | — | — | WO | claimed |
| WO-2025018283-A1 | MEDICAL INSTRUMENT AND MANUFACTURING METHOD THEREFOR | テルモ株式会社 | 2025-01-23 | — | — | WO | disclosed |
| CN-113736307-A | Hole-transporting ink composition, light-emitting device, and method for producing light-emitting device | 三星显示有限公司 | 2021-12-03 | — | — | CN | disclosed |
| EP-1819876-A2 | PAPER SIZING AGENT | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-22 | — | — | EP | disclosed |
| WO-2006058711-A2 | PAPER SIZING AGENT | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-08 | — | — | WO | disclosed |
| EP-1509568-A1 | RUBBER MIXTURES CONTAINING QUATERNARY POLYMERS AND POLAR SOFTENING AGENTS | Lanxess Deutschland GmbH (DE) | 2005-03-02 | — | — | EP | disclosed |
| WO-2003099921-A1 | RUBBER MIXTURES CONTAINING QUATERNARY POLYMERS AND POLAR SOFTENING AGENTS | LANXESS DEUTSCHLAND GMBH (DE) | 2003-12-04 | — | — | WO | disclosed |
| US-20020120086-A1 | Quaternary polymers with functional amine groups field of the invention | BAYER AKTIENGESELLSCHAFT (DE) | 2002-08-29 | — | — | US | disclosed |
| WO-2002020632-A1 | QUATERNARY POLYMERS WITH FUNCTIONAL AMINE GROUPS | BAYER AKTIENGESELLSCHAFT (DE) | 2002-03-14 | — | — | WO | disclosed |
| EP-0412388-A2 | Process of preparation of fine particles of polymers in powder form | BASF Aktiengesellschaft (DE) | 1991-02-13 | — | — | EP | disclosed |